Dr. Walsh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1190 5th Avenue
Guggenheim Pav Mt Sinai Hosp Ruttenberg Treatment Ctr
New York, NY 10029Phone+1 212-241-6756Fax+1 212-423-0522
Education & Training
- National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1988 - 1993
- University of North Carolina HospitalsResidency, Internal Medicine, 1986 - 1988
- Tulane University School of MedicineClass of 1986
Certifications & Licensure
- NY State Medical License 2002 - 2025
- FL State Medical License 2021 - 2023
- MD State Medical License 1988 - 2015
- NC State Medical License 1987 - 2003
- LA State Medical License 1986 - 1986
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Open-Label Single Ascending Dose of Adeno-associated Virus Serotype 8 Factor IX Gene Therapy in Adults With Hemophilia B Start of enrollment: 2013 Feb 11
Publications & Presentations
PubMed
- 95 citationsBAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A. Konkle, Christopher E. Walsh, Miguel A. Escobar, Neil C. Josephson, Guy Young
Blood. 2021-02-11 - 23 citationsLedipasvir–sofosbuvir and sofosbuvir plus ribavirin in patients with chronic hepatitis C and bleeding disordersChristopher E. Walsh, Kimberly A. Workowski, Norah A. Terrault, Paul E. Sax, Alice J. Cohen
Haemophilia. 2017-03-01 - 119 citationsRegulated high level expression of a human gamma-globin gene introduced into erythroid cells by an adeno-associated virus vector.Christopher E. Walsh, Johnson M. Liu, Xiaodong Xiao, Neal S. Young, Arthur W. Nienhuis
Proceedings of the National Academy of Sciences of the United States of America. 1992-08-01
Press Mentions
- Gene Therapy May Be Cure for Some with Rare Blood DisorderApril 19th, 2018
Grant Support
- Prevention Of The Complications Of Hemophilia Thru Hemophilila Treatment CentersCenters For Disease Control And Prevention2006–2008
- Genetics Of Human Epilepsy And Cognitive DisordersNational Center For Research Resources2004–2007
- Gene Therapy For The HemophiliasNational Heart, Lung, And Blood Institute2002–2006
- Gene Transfer Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2002–2004
- Gene Therapy For The HemophiliasNational Heart, Lung, And Blood Institute2002
- Gene Transfer Of Hematopoietic Stem CellsNational Heart, Lung, And Blood Institute2001–2002
- Signal Transduction Pathways For Neuronal MigrationNational Institute Of Neurological Disorders And Stroke1999–2002
- Gene Therapy Transfer Of Fanconi Anemia Group A GeneNational Center For Research Resources2000
- Fanconi Anemia--Pathophysiology And TreatmentNational Cancer Institute1998–1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: